|
Volumn 16, Issue 3, 2002, Pages 105-110
|
Nitric oxide plays an insignificant role in direct vasodilator effects of calcium channel blockers in healthy humans
a a a a a a |
Author keywords
Blood flow; Calcium channel blocker; Endothelium; Nitric oxide
|
Indexed keywords
ACETYLCHOLINE;
CALCIUM CHANNEL BLOCKING AGENT;
DILTIAZEM;
N(G) METHYLARGININE;
NICARDIPINE;
NIFEDIPINE;
NITRIC OXIDE;
ADULT;
ARTICLE;
BIOAVAILABILITY;
BLOOD PRESSURE MEASUREMENT;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG MECHANISM;
FOREARM BLOOD FLOW;
HEART RATE;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
VASCULAR ENDOTHELIUM;
VASCULAR RESISTANCE;
VASODILATATION;
VEIN OCCLUSION PLETHYSMOGRAPHY;
ADULT;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
DILTIAZEM;
ENDOTHELIUM, VASCULAR;
ENZYME INHIBITORS;
FOREARM;
HEART RATE;
HUMANS;
MALE;
NICARDIPINE;
NIFEDIPINE;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
OMEGA-N-METHYLARGININE;
PLETHYSMOGRAPHY;
VASODILATION;
VASODILATOR AGENTS;
|
EID: 0036237920
PISSN: 09108327
EISSN: None
Source Type: Journal
DOI: 10.1007/s003800200004 Document Type: Article |
Times cited : (6)
|
References (15)
|